BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 27279046)

  • 1. Opportunities for Translation from the Bench: Therapeutic Intervention of the JAK/STAT Pathway in Neuroinflammatory Diseases.
    Liu Y; Gibson SA; Benveniste EN; Qin H
    Crit Rev Immunol; 2015; 35(6):505-27. PubMed ID: 27279046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of the janus kinase/signal transducer and activator of transcription signaling pathway in multiple sclerosis and the animal model of experimental autoimmune encephalomyelitis.
    Benveniste EN; Liu Y; McFarland BC; Qin H
    J Interferon Cytokine Res; 2014 Aug; 34(8):577-88. PubMed ID: 25084174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic efficacy of suppressing the Jak/STAT pathway in multiple models of experimental autoimmune encephalomyelitis.
    Liu Y; Holdbrooks AT; De Sarno P; Rowse AL; Yanagisawa LL; McFarland BC; Harrington LE; Raman C; Sabbaj S; Benveniste EN; Qin H
    J Immunol; 2014 Jan; 192(1):59-72. PubMed ID: 24323580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Specific Roles of JAK/STAT Signaling Pathway in Sepsis.
    Cai B; Cai JP; Luo YL; Chen C; Zhang S
    Inflammation; 2015 Aug; 38(4):1599-608. PubMed ID: 25676437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baricitinib Ameliorates Experimental Autoimmune Encephalomyelitis by Modulating the Janus Kinase/Signal Transducer and Activator of Transcription Signaling Pathway.
    Dang C; Lu Y; Chen X; Li Q
    Front Immunol; 2021; 12():650708. PubMed ID: 33927721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BJ-2266 ameliorates experimental autoimmune encephalomyelitis through down-regulation of the JAK/STAT signaling pathway.
    You Z; Timilshina M; Jeong BS; Chang JH
    Eur J Immunol; 2017 Sep; 47(9):1488-1500. PubMed ID: 28681958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the JAK/STAT signaling pathway in regulation of innate immunity in neuroinflammatory diseases.
    Yan Z; Gibson SA; Buckley JA; Qin H; Benveniste EN
    Clin Immunol; 2018 Apr; 189():4-13. PubMed ID: 27713030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. JAK/STAT pathway modulation: Does it work in dermatology?
    Gündüz Ö
    Dermatol Ther; 2019 May; 32(3):e12903. PubMed ID: 30964573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An insight into JAK-STAT signalling in dermatology.
    Palanivel JA; Macbeth AE; Chetty NC; Levell NJ
    Clin Exp Dermatol; 2014 Jun; 39(4):513-8. PubMed ID: 24825142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The involvement of JAK/STAT signaling pathway in the treatment of Parkinson's disease.
    Lashgari NA; Roudsari NM; Momtaz S; Sathyapalan T; Abdolghaffari AH; Sahebkar A
    J Neuroimmunol; 2021 Dec; 361():577758. PubMed ID: 34739911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. JAK/STAT pathway in Drosophila immunity.
    Myllymäki H; Rämet M
    Scand J Immunol; 2014 Jun; 79(6):377-85. PubMed ID: 24673174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of JAK/STAT signaling in the pathogenesis of inflammatory bowel disease.
    Coskun M; Salem M; Pedersen J; Nielsen OH
    Pharmacol Res; 2013 Oct; 76():1-8. PubMed ID: 23827161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokine shifts and tolerance in experimental autoimmune encephalomyelitis.
    Chitnis T; Khoury SJ
    Immunol Res; 2003; 28(3):223-39. PubMed ID: 14713716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pleiotropy and redundancy of STAT proteins in early pregnancy.
    Maj T; Chelmonska-Soyta A
    Reprod Domest Anim; 2007 Aug; 42(4):343-53. PubMed ID: 17635769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. STAT proteins in innate immunity during sepsis: lessons from gene knockout mice.
    Matsukawa A
    Acta Med Okayama; 2007 Oct; 61(5):239-45. PubMed ID: 17971840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-7/IL-7 Receptor Signaling Differentially Affects Effector CD4+ T Cell Subsets Involved in Experimental Autoimmune Encephalomyelitis.
    Arbelaez CA; Glatigny S; Duhen R; Eberl G; Oukka M; Bettelli E
    J Immunol; 2015 Sep; 195(5):1974-83. PubMed ID: 26223651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Connection between JAK/STAT and PPARγ Signaling During the Progression of Multiple Sclerosis: Insights into the Modulation of T-Cells and Immune Responses in the Brain.
    Kumar N; Sharma N; Mehan S
    Curr Mol Pharmacol; 2021; 14(5):823-837. PubMed ID: 33645493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The JAK-STAT pathway: a therapeutic target in hematological malignancies.
    Ferrajoli A; Faderl S; Ravandi F; Estrov Z
    Curr Cancer Drug Targets; 2006 Dec; 6(8):671-9. PubMed ID: 17168672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New Insights into the Role of IL-1β in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis.
    Lin CC; Edelson BT
    J Immunol; 2017 Jun; 198(12):4553-4560. PubMed ID: 28583987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glia maturation factor regulation of STAT expression: a novel mechanism in experimental autoimmune encephalomyelitis.
    Zaheer S; Wu Y; Bassett J; Yang B; Zaheer A
    Neurochem Res; 2007 Dec; 32(12):2123-31. PubMed ID: 17551829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.